Search Results for 'hpapi manufacturing'
-
APIs | Scale-up/Technology Transfer
How To Select The Ideal HPAPI Manufacturing Partner
To ensure safety during HPAPI production, manufacturers must have the knowledge to effectively use containment and design high-quality equipment.
-
cGMP Manufacture | Cytotoxics and High Potency Manufacturing
The Evolution of HPAPI Manufacturing for CDMOs
The demand for highly potent APIs has been steadily increasing, driven by the development of targeted therapies in oncology and other disease areas.Adam Kujath, EVP and Site Head, Germantown, Sterling Pharma Solutions 10.12.23
-
Cytotoxics and High Potency Manufacturing | Facilities
HPAPI Manufacturing Trends
Oncology drugs, advancements in manufacturing technology, and a rise in capacity to meet greater demand drive market growth.Tim Wright, Editor, Contract Pharma 09.13.23
-
APIs
Explore the Next Generation Manufacturing of the Most Potent Compounds in Pharma
MilliporeSigma's new HPAPI contract manufacturing facility brings unmatched capacity to the market.
-
Breaking News | Cytotoxics and High Potency Manufacturing | Facilities | Industry News
Novasep Expands HPAPI Manufacturing Capacity
Responds to increasing customer demand for manufacturing services for antibody drug conjugates.Tim Wright, Editor, Contract Pharma 05.13.21
-
Cytotoxics and High Potency Manufacturing
Handling & Assessing HPAPIs
As oncology pipelines grow, so too is the demand for highly potent materials, which require careful handling and containment.Jason Korbel, Technical Services Manager, Cambrex Charles City 09.16.19
-
Cytotoxics and High Potency Manufacturing
API to ADC: A Journey Through High Potency
This class of compounds represents a major advance in oncology research and treatment application.Maurits Janssen, Head Commercial Development API, Lonza Pharma & Biotech 09.16.19
-
Bio News | Breaking News | Cytotoxics and High Potency Manufacturing | Facilities | Industry News
Lonza to Expand HPAPI Development and Manufacturing Capacity
Will develop new facilities at Visp site; enters long term mfg. agreement with AstraZeneca06.14.19
-
APIs | Cytotoxics and High Potency Manufacturing
HPAPI Market Trends
Rising demand for targeted cancer and other treatments driving HPAPI growth.Nigel Walker, That’s Nice/Nice Insight 09.11.18
-
HPAPI Outsourcing Likely to Gain Traction
A number of highly potent drugs will soon fall into the generic domainS. Harachand, Contributing Editor 09.11.18
-
APIs | Cytotoxics and High Potency Manufacturing | Industry News
